About Index Trending news
Analyze
Top 50 Pricing
Genkyotex S.A

Genkyotex S.A

Work at Genkyotex S.A? Add yourself to this profile

Genkyotex S.A

Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.

Elsewhere

Alexa global traffic share

07 Jan 2015
$21,000,000
Venture capital (Series D)
VI Partners, Neomed Management, Edmond de Rothschild Venture Capital, +3
09 Jul 2012
$26,000,000
Venture capital (Series C)
MP Healthcare Venture Management, Edmond de Rothschild Venture Capital, Eclosion SA, +1
06 May 2008
$3,820,000
Venture capital
Societe Generale Asset Management
30 Jan 2006
$1,550,000
Venture capital
Eclosion SA